1. Home
  2. CURR vs GLSI Comparison

CURR vs GLSI Comparison

Compare CURR & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

SELL

Current Price

$1.88

Market Cap

208.8M

ML Signal

SELL

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

SELL

Current Price

$19.34

Market Cap

236.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CURR
GLSI
Founded
2013
2006
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.8M
236.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CURR
GLSI
Price
$1.88
$19.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $57.50
AVG Volume (30 Days)
★ 243.0K
196.2K
Earning Date
12-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $46,435,412.00
N/A
Revenue This Year
$12.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$7.78
52 Week High
$5.08
$34.10

Technical Indicators

Market Signals
Indicator
CURR
GLSI
Relative Strength Index (RSI) 36.11 57.05
Support Level $1.43 $14.07
Resistance Level $3.50 $19.36
Average True Range (ATR) 0.23 1.76
MACD 0.03 0.44
Stochastic Oscillator 64.18 64.42

Price Performance

Historical Comparison
CURR
GLSI

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: